AMAM News and Press, Ambrx Biopharma Inc. American Depositary Shares (each representing seven) From 10/16/23

2023-10-16 17:25:11 ET Gainers: Y-mAbs Therapeutics ( YMAB ) +6% . CrossFirst Bankshares ( CFB ) +4% . Iris Energy  ( IREN ) +4% . Vir Biotechnology ( VIR ) +3% . Service Properties Trust ( SVC ) +3% . Losers: NetSco...

2023-10-16 13:36:37 ET Gainers: Tempest Therapeutics ( TPST ) +98% . Momentus ( MNTS ) +51% . PCTEL ( PCTI ) +47% . Almacenes Exito ( EXTO ) +33% . Mereo Biopharma Group Plc ( MREO ) +30% . Rani Therapeutics Holdings ( RANI...

2023-10-16 09:09:21 ET DENVER, Colo., Oct 16, 2023 ( www.247marketnews.com )- Ambrx Biopharma, Inc. (NASDAQ: AMAM) stated, this morning, that it published two abstracts detailing updated safety and efficacy data from the ongoing Phase 1/2 trial, APEX-01 (NCT04662580), evaluating ARX517 ...

Newly published abstract regarding dose escalation patients provides key updates including: ≥50% PSA reduction observed across putative therapeutic dose levels ≥2.0 mg/kg – 3 of 3 in Cohort 6 (2.0 mg/kg), 2 of 3 in Cohort 7 (2.4 mg/kg) and 2 of 3 in Cohort 8 (2.88 m...

2023-10-13 15:00:54 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...

SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that it will host an in-person key opinion leader (KOL) event during the European Society for Medical Oncology (ESMO) Congress 2023. The event will take place...

2023-09-21 19:47:58 ET Shares of Ambrx Biopharma (NASDAQ: AMAM) were up more than 27% for the week as of Thursday's close, according to data provided by S&P Global Market Intelligence . The clinical-stage biotech closed last week at $10.25, then rose as high as $12.20 on...

2023-09-20 11:41:55 ET Ambrx Biopharma ( NASDAQ: AMAM ) disclosed on Sept. 19 that Cormorant Asset Management purchased 2.15M shares in the company from a period between Sept.15 to 18. The shares were purchased at a price between $9.05- $9.24. Cormorant Asset Manageme...

Morgan Stanley Fireside Chat Replay Now Available SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that Daniel J. O’Connor, Chief Executive Officer and President of Ambrx, will participate in ...

2023-09-15 13:11:06 ET Gainers: MSP Recovery ( LIFW ) +199% . AERWINS Technologies ( AWIN ) +104% . AgriFORCE Growing Systems Ltd. ( AGRI ) +40% . RayzeBio ( RYZB ) +37% . Novonix Limited ( NVX ) +31% . Greenland Technologies...